During the past decade, Alliance Urology Specialists conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 18 clinical trials were completed, i.e. on average, 163.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alliance Urology Specialists" #1 sponsor was "Ferring Pharmaceuticals" with 7 trials, followed by "Allergan" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Valencia Technologies Corporation" with 3 trials sponsored and "Abbott" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alliance Urology Specialists" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Data & Inference, Inc." with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Novella Clinical" with 2 trials as a collaborator and "TARIS Biomedical, Inc." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Alliance Urology Specialists" are "Prostate Cancer" (12 trials), "Overactive Bladder" (9 trials), "Interstitial Cystitis" (4 trials), "Urinary Bladder, Overactive" (3 trials) and "Bladder Cancer" (2 trials). Many other conditions were trialed in "Alliance Urology Specialists" in a lesser frequency.

Most popular intervention types in "Alliance Urology Specialists" are "Drug" (24 trials), "Device" (9 trials), "Biological" (4 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (7 trials), "Placebo" (6 trials), "Apaziquone" (2 trials), "Atrasentan" (2 trials) and "Enzalutamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alliance Urology Specialists" are 20 trials for "All" genders, 15 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Alliance Urology Specialists". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Alliance Urology Specialists, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Alliance Urology Specialists, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".